{
    "nct_id": "NCT04208490",
    "official_title": "Implementation and Effectiveness Trial of HN-STAR",
    "inclusion_criteria": "* Age ≥18 years.\n* Diagnosis of primary or locoregionally recurrent head and neck squamous cell carcinoma, specifically oral cavity, larynx, oropharynx, hypopharynx, and unknown squamous cell carcinoma primary.\n* Completed chemotherapy and/or radiation therapy with curative intent for head and neck squamous cell carcinoma ≤ 24 months prior to designated clinician visit.\n* Deemed free of disease at last assessment.\n* Cognitively and physically able to complete study survey per local NCORP site staff discretion.\n* Scheduled for a clinic visit with a provider who has agreed to participate in this study and meets requirements for the arm to which their practice has been assigned (the practice designated clinician) for routine follow-up.\n* Willing to complete study assessments 3, 6, and 9 months after the designated clinic visit either 1) remotely (via telephone or videoconference using smartphone, tablet, or computer) or 2) at the clinic to complete study assessments on a clinic tablet or computer.\n\nSurvivor\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* In active cancer treatment (including hormone therapy) for any other cancer, excluding local therapy for non-melanoma skin cancer.\n* Evidence of prior cancer (excluding non-melanoma skin cancer) within 3 years of the designated clinician visit.\n* Head and neck tumor histology of lymphoma, adenocarcinoma or melanoma.\n* Recurrent, persistent, or progressive disease at last assessment (per scan or clinical assessment).\n* Does not speak or read English, because the HN-STAR tool is only available in English at this time.\n* Received only surgery as treatment for head and neck cancer.\n* Current, planned enrollment, or in follow-up on another interventional symptom management study protocol, as per patient self-report or research staff members' knowledge at the time of consent. Concurrent participation in treatment or imaging studies is allowed.\n\nDesignated Clinician Inclusion Criteria:\n\n* Age > = 18 years\n* MD, DO, NP, or PA\n* Able to speak and read English, because the HN-STAR tool is only available in English at this time.\n* Routinely provides care for cancer patients or survivors.\n* Willing to complete study-specific trainings and incorporate HN-STAR or provide usual care in a routine follow-up care visit\n\nStakeholders Inclusion Criteria:\n\n* Age > = 18\n* Member of the practice clinical or administrative team who is involved in the oversight of the delivery of head and neck cancer survivorship care or who would make decisions about implementing head and neck survivorship tools such as HN-STAR. This could include clinic administrators, nurse navigators, key clinical team members, program directors, and other staff (e.g., service line or nursing leaders).\n* Employed for at least one month at the practice.\n* Able to speak and reads English, because the HN-STAR tool is only available in English at this time.\n\nStakeholder Exclusion Criteria:\n\n* Is the designated clinician at the practice.\n\nPrimary Care Provider Inclusion Criteria:\n\n* Provides primary care (general preventative care) to a survivor enrolled in the HN-STAR study.\n* Age >= 18\n* MD, DO, NP, or PA\n\nPrimary Care Provider Exclusion Criteria:\n\n* Provides Oncology Care",
    "miscellaneous_criteria": "Survivor"
}